Mason Street Advisors’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,160
Closed -$506K 975
2020
Q4
$506K Sell
11,160
-45
-0.4% -$1.57K 0.01% 1166
2020
Q3
$308K Sell
11,205
-679
-6% -$22.1K 0.01% 1236
2020
Q2
$438K Buy
11,884
+967
+9% +$36.1K 0.01% 1121
2020
Q1
$353K Hold
10,917
0.01% 1110
2019
Q4
$447K Buy
10,917
+294
+3% +$11.6K 0.01% 1167
2019
Q3
$378K Buy
10,623
+350
+3% +$14.2K 0.01% 1182
2019
Q2
$528K Buy
10,273
+448
+5% +$22.4K 0.01% 1082
2019
Q1
$563K Buy
9,825
+476
+5% +$23.6K 0.01% 1091
2018
Q4
$392K Buy
9,349
+644
+7% +$37.8K 0.01% 1124
2018
Q3
$657K Buy
8,705
+958
+12% +$69K 0.01% 1010
2018
Q2
$556K Buy
+7,747
New +$370K 0.01% 1036

Other funds holding RGNX